Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer

转移性结直肠癌治疗

维持治疗疗效评估

This is a phase II, randomized, multi-center, open-label, parallel-group study to evaluate the progression-free survival during maintenance therapy. Eligible patients will be treated within a 12-week

NIAID Data Ecosystem90

Capecitabine as maintenance chemotherapy in advanced colorectal cancer

结直肠癌药物治疗

维持治疗疗效评估

Interventions: test group:Maintain with capecitabine after XELOX or FOLFOX treatment;control group:XELOX or FOLFOX Primary outcome(s): PFS Study Design: Randomized parallel controlled trial

NIAID Data Ecosystem40

Results for treatment maintenance phases on primary and secondary measures.

临床数据分析

维持治疗疗效评估

Results for treatment maintenance phases on primary and secondary measures.

Figshare2024-12-05 更新20